Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Omnitrope Pen 10 10mg/1.5ml inj cartridges
0605010S0BHACBL
|
Omnitrope | Somatropin | Endocrine System | No data available |
|
On Call Now testing strips
0601060D0BZAAA0
|
On Call Now (Reagent) | Glucose blood testing reagents | Endocrine System | No data available |
|
On Call Plus testing strips
0601060D0CDAAA0
|
On-Call Plus (Reagent) | Glucose blood testing reagents | Endocrine System | No data available |
|
Oncaspar 3,750unit powder for solution for injection vials
0801050BABBACAB
|
Oncaspar | Pegaspargase | Malignant Disease and Immunosuppression | No data available |
|
Oncaspar 3,750units/5ml inj vials (Imported)
0801050BABBAAAA
|
Oncaspar | Pegaspargase | Malignant Disease and Immunosuppression | No data available |
|
Oncaspar 3,750units/5ml solution for injection vials
0801050BABBABAA
|
Oncaspar | Pegaspargase | Malignant Disease and Immunosuppression | No data available |
|
OncoTICE 12.5mg instil vials
0802040X0BBAAAA
|
OncoTICE | Bacillus calmette-guerin (B.C.G.) | Malignant Disease and Immunosuppression | No data available |
|
Oncovin 1mg/1ml solution for injection vials
0801040M0BBADAE
|
Oncovin | Vincristine sulfate | Malignant Disease and Immunosuppression | No data available |
|
Ondemet 4mg tablets
0406000S0BCACAB
|
Ondemet | Ondansetron hydrochloride | Central Nervous System | No data available |
|
Ondemet 4mg/2ml solution for injection ampoules
0406000S0BCAAAA
|
Ondemet | Ondansetron hydrochloride | Central Nervous System | No data available |
|
Ondemet 8mg tablets
0406000S0BCADAC
|
Ondemet | Ondansetron hydrochloride | Central Nervous System | No data available |
|
Ondemet 8mg/4ml solution for injection ampoules
0406000S0BCABAD
|
Ondemet | Ondansetron hydrochloride | Central Nervous System | No data available |
|
One A Day Womens 50+ Healthy Advantage tablets
091000000BBXHBU
|
Proprietary compound preparation BNF 0910000 | Other compound vitamin/mineral formulation preparations | Nutrition and Blood | No data available |
|
One-Alpha 1micrograms/0.5ml solution for injection ampoules
0906040B0BBAFAF
|
One-Alpha | Alfacalcidol | Nutrition and Blood | No data available |
|
One-Alpha 2micrograms/1ml solution for injection ampoules
0906040B0BBAGAG
|
One-Alpha | Alfacalcidol | Nutrition and Blood | No data available |
|
OneTouch FinePoint lancets 0.5mm/25gauge
21010900570
|
OneTouch FinePoint lancets 0.5mm/25gauge | Other Appliances | Appliances | No data available |
|
OneTouch testing strips
0601060D0BHAAA0
|
OneTouch (Reagent) | Glucose blood testing reagents | Endocrine System | No data available |
|
OneTouch Ultra testing strips
0601060D0BHABA0
|
OneTouch (Reagent) | Glucose blood testing reagents | Endocrine System | No data available |
|
OneTouch Vita testing strips
0601060D0BHACA0
|
OneTouch (Reagent) | Glucose blood testing reagents | Endocrine System | No data available |
|
Onexila XL 80mg tablets
0407020ADBQADAI
|
Onexila XL | Oxycodone hydrochloride | Central Nervous System | No data available |
|
Onivyde pegylated liposomal 43mg/10ml concentrate for inf
0801050Q0BCAAAE
|
Onivyde | Irinotecan hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Onkotrone 20mg/10ml solution for infusion vials
0801020R0BCAAAA
|
Onkotrone | Mitoxantrone | Malignant Disease and Immunosuppression | No data available |
|
Onkotrone 25mg/12.5ml solution for infusion vials
0801020R0BCABAB
|
Onkotrone | Mitoxantrone | Malignant Disease and Immunosuppression | No data available |
|
Onovus Solo colostomy bag 13mm-45mm light grey
23355903731
|
Onovus Solo colostomy bag 13mm-45mm light grey | Colostomy Bags | Stoma Appliances | No data available |
|
Onsenal 400mg capsules
1001010AHBCAAAD
|
Onsenal | Celecoxib | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.